about
Functional coupling between nitric oxide synthesis and VIP release within enteric nerve terminals of the rat: involvement of protein kinase G and phosphodiesterase 5Endoscopic treatment of a Zenker's diverticulum using argon plasma coagulation in a patient with massive cachexia and esophageal obstruction: a case report and review of literature.Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.HDAC3 is linked to cell cycle machinery in MiaPaCa2 cells by regulating transcription of skp2.HMGA1 controls transcription of insulin receptor to regulate cyclin D1 translation in pancreatic cancer cells.Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations.IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription in vivo.Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells.Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.Author Correction: Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations.SnapShot: Class I PI3K isoform signaling.Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma.Repeated SBRT for in- and out-of-field recurrences in the liverSimultaneous perforation of three major liver blood vessels by percutaneous transhepatic biliary drainageOxaliplatin in perioperative chemotherapy for gastric and gastroesophageal junction (GEJ) adenocarcinomaRAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance
P50
Q28345164-AF9DAAF4-C9FC-4B7F-8D33-253A0E28AACFQ31108665-F5D5CCB1-E7F8-40E3-8459-7D7977DA70D4Q33283940-B6FA7F6B-C33A-46FF-BB71-51396819ABFEQ36167042-70164579-078A-4180-96DF-05D720E40C93Q36484244-3794CC7E-2920-4D1F-9423-38953DE80912Q37725589-E2217432-7C32-409E-89A6-A99B4618484CQ40106493-82498598-F862-4BB2-B44A-C65DEB80A8EBQ40131330-FAED622C-BAF7-42AF-8BC7-9F6275DABF82Q40136040-E9953CBA-817F-466C-BB28-D21F0D2BD8BFQ40244730-B6CA6078-CA7E-4733-970F-263EC01ECD47Q41676808-A20EFE45-F1E3-4ACD-A586-2DB940F9E26DQ42074608-30F93A48-18E2-4D76-B10B-201F4E67DB4CQ47137682-FCFD21D0-17F7-4814-A3A8-FCA17118A8CEQ47139914-EF211208-245C-451D-9CE9-500F37C0B757Q47762520-33C47552-4241-4189-BFF1-1942A7E65D0EQ52576084-23B8FB45-5F5A-438F-878F-CFFAB081D8B8Q57800089-07AD34F5-8A46-4701-B269-C0BD490E748CQ74818106-7F599B02-5439-444A-94CA-372E0B87659BQ91810161-9B73C6E8-80D5-485D-9526-4DF08F715AD9Q93138003-2478E6CD-1E18-47DC-B95F-4C53B131D79A
P50
description
researcher
@en
wetenschapper
@nl
name
R Fritsch
@en
R Fritsch
@nl
type
label
R Fritsch
@en
R Fritsch
@nl
prefLabel
R Fritsch
@en
R Fritsch
@nl
P106
P31
P496
0000-0001-9639-3213